89060-36-6

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 10 carbon (C), 8 hydrogen (H), 4 nitrogen (N), and 1 oxygen (O) atoms.

Explanation

The structure of the compound is characterized by a 1H-1,2,4-triazole ring, which is a five-membered ring containing three nitrogen atoms and two carbon atoms. The 5-carboxaldehyde group is attached to the triazole ring, and a 1-methyl-3-phenyl substitution is present on the triazole ring.

Explanation

A heterocyclic compound is a cyclic compound containing atoms of at least two different elements. In this case, the triazole ring contains nitrogen atoms, making it a heterocyclic compound.

Explanation

The compound has several functional groups that contribute to its chemical properties and reactivity. These include the triazole ring, a carboxaldehyde group (C=O), a methyl group (-CH3), and a phenyl group (C6H5).

Explanation

The compound is commonly used as a precursor in the synthesis of various organic compounds, including pharmaceuticals and agrochemicals. It also has potential as a building block in the design of new materials and bioactive compounds.

Explanation

The presence of the 1-methyl-3-phenyl substitution on the triazole ring contributes to the unique properties and reactivity of the compound, making it a valuable intermediate in organic chemistry.

Explanation

Although not explicitly mentioned in the material, most organic compounds with molecular weights in the range of C10H8N4O are typically solids at room temperature.

Explanation

The compound is likely soluble in organic solvents such as dichloromethane, ethyl acetate, or acetone due to its nonpolar nature and the presence of aromatic rings.

Explanation

The compound is expected to be stable under normal conditions, such as room temperature and atmospheric pressure, as it does not contain any highly reactive functional groups.

Explanation

As with many organic compounds, 1H-1,2,4-Triazole-5-carboxaldehyde, 1-methyl-3-phenylmay pose health risks, such as being an irritant or toxic, if not handled properly. It is essential to follow safety guidelines and use appropriate protective equipment when working with 1H-1,2,4-Triazole-5-carboxaldehyde, 1-methyl-3-phenyl-.

Structure

1H-1,2,4-Triazole-5-carboxaldehyde, 1-methyl-3-phenyl-

Heterocyclic Compound

Yes

Functional Groups

Triazole ring, carboxaldehyde group, methyl group, and phenyl group

Application

Organic synthesis, pharmaceuticals, agrochemicals, and materials design

Reactivity

Influenced by 1-methyl-3-phenyl substitution

Physical State

Likely solid at room temperature

Solubility

Soluble in organic solvents

Stability

Stable under normal conditions

Hazards

Potential irritant or toxic

Upstream product

• 30216-01-4 2-phenyl-2-oxazolin-4-one 
• 26254-08-0 (2-methyl-5-phenyl-2H-[1,2,4]triazol-3-yl)-methanol 
• 138-89-6 p-dimethylaminonitrosobenzene 
• 26254-15-9 5-chloromethyl-1-methyl-3-phenyl-1H-[1,2,4]triazole 

Downstream Products

• 89060-34-4 4-Dimethylamino-N-<(1-methyl-3-phenyl-1,2,4-triazol-5-yl)methylen>anilin 
• 89060-82-2 5-Dipiperidinomethyl-1-methyl-3-phenyl-1,2,4-triazol 
• 89060-68-4 1-Methyl-3-phenyl-5-piperidinomethyl-1,2,4-triazol 
• 89060-75-3 (2-Methyl-5-phenyl-2H-[1,2,4]triazol-3-yl)-piperidin-1-yl-methanol 

Relevant academic research and scientific papers

HETEROAROMATIC ARYL TRIAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS

This invention is directed to compounds (Formula 1), which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable car

3-Phenyl-1,2,4-triazole-5-carbaldehydes Substituted in Position 1

The aldehydes 7 - first examples of the yet unknown class of 1,2,4-triazole-5-carbaldehydes substituted in position 1 - can be obtained in excellent yield by lead tetraacetate oxidation of 2; the Kroehnke reaction with 5 provides an alternative route.Due